Inspire
Not Recruiting
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
A prospective evaluation on the Influence of NT5c1A antibodies on disease progression, clinical phenotype and blood and muscle biomarkers in sporadic Inclusion Body Myositis
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
10 May 2024.
Study ID: 849187
